Clinical Trial Update: ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

View source ↗

Summary

This clinical trial update reports on using dynamic monitoring of circulating tumor DNA (ctDNA) by next-generation sequencing to assess prognosis in Stage I non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer Stage I | Status: COMPLETED